Abdera Therapeutics
Gibby Goodworth is an accomplished professional with extensive experience in project management within the biopharmaceutical sector. Currently serving as Executive Director and Project Team Leader at Abdera Therapeutics since December 2022, Gibby has previously held senior roles at Clovis Oncology, including Senior Director and Director of Project Management. Prior experience includes a position as Director of Program Management at Audentes Therapeutics and several roles at Nektar Therapeutics and FivePrime, progressing from Associate Project Manager to Research Associate IV. Gibby holds a Certificate in Project Management for Biopharmaceuticals from the University of California, Berkeley, and completed a project management boot camp exam prep at a project management academy.
This person is not in any teams
This person is not in any offices
Abdera Therapeutics
1 followers
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy radio-isotopes to tumors and metastatic cancer lesions. This new class of drugs holds tremendous untapped therapeuticand commercial potential, and has generated over $10B in recent M&A, financings, and product launches – and are expected to comprise 70% of the $30B nuclear medicine market by 2030.It was launched by adMare BioInnovations, Canada’s global life sciences venture, in partnership with industry leaders AbCellera, and some of the country’s most successful scientist entrepreneurs.